A revised draft proposal to create a process to expand the list of nutrients that require a warning under California's Proposition 65 "contains significant ambiguities" and should be dismissed, says the Council for Responsible Nutrition
Join thousands of industry professionals who rely on HBW Insight for daily insights
Already a subscriber?
The US FTC’s contention that ‘notice and choice’ has failed as the cornerstone of consumer privacy regulation and must be abandoned in favor of data minimization and other more stringent measures does not adequately account for the complexity of business practices and consumer behavior, FTC commissioner Melissa Holyoak asserted at the NAD’s 2024 Annual Conference.
FTC Commissioner Melissa Holyoak says the agency has acted outside the bounds afforded by Congress, citing several areas within consumer protection, including a recent update to the final rule for the Health Breach Notification Rule and the commission’s use of notices of penalty offense to serve as the basis for Section 5 settlements.
At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”
Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
Estee Lauder says tariffs will hit its bottom line by $100m in fiscal year 2026, as it continues to work toward mitigation strategies. For the full fiscal year 2026, ELC estimates its sales will be in line with or ahead of prestige beauty in key markets, with reported sales in the range of 2%-5%.
Holistic Alternative Recovery Trust says FDA should review data and other information available about the safety of all kratom extracts before it moves ahead on its proposal to recommend Schedule I controlled substance for 7-OH.
Supporters of planned FDA action to recommend DEA schedule 7-OH include Global Kratom Coalition and Regulatory Service International consultancy firm. AHPA also supports FDA decision but says marketers of kratom extract mitragynine likely aren’t out of the weeds as far as questions about safety.
